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Rho Kinase Signaling Pathways During Stretch in Primary Alveolar Epithelia
Abstract
Alveolar epithelial cells (AECs) maintain integrity of the blood-gas barrier with actin-anchored intercellular
tight junctions. Stretched type I-like AECs undergo magnitude- and frequency-dependent actin
cytoskeletal remodeling into perijunctional actin rings. On the basis of published studies in human
pulmonary artery endothelial cells (HPAECs), we hypothesize that RhoA activity, Rho kinase (ROCK)
activity, and phosphorylation of myosin light chain II (MLC2) increase in stretched type I-like AECs in a
manner that is dependent on stretch magnitude, and that RhoA, ROCK, or MLC2 activity inhibition will
attenuate stretch-induced actin remodeling and preserve barrier properties. Primary type I-like AEC
monolayers were stretched biaxially to create a change in surface area (ΔSA) of 12%, 25%, or 37% in a
cyclic manner at 0.25 Hz for up to 60 min or left unstretched. Type I-like AECs were also treated with Rho
pathway inhibitors (ML-7, Y-27632, or blebbistatin) and stained for F-actin or treated with the myosin
phosphatase inhibitor calyculin-A and quantified for monolayer permeability. Counter to our hypothesis,
ROCK activity and MLC2 phosphorylation decreased in type I-like AECs stretched to 25% and 37% ΔSA
and did not change in monolayers stretched to 12% ΔSA. Furthermore, RhoA activity decreased in type Ilike AECs stretched to 37% ΔSA. In contrast, MLC2 phosphorylation in HPAECs increased when HPAECs
were stretched to 12% ΔSA but then decreased when they were stretched to 37% ΔSA, similar to type I-like
AECs. Perijunctional actin rings were observed in unstretched type I-like AECs treated with the Rho
pathway inhibitor blebbistatin. Myosin phosphatase inhibition increased MLC2 phosphorylation in
stretched type I-like AECs but had no effect on monolayer permeability. In summary, stretch alters RhoA
activity, ROCK activity, and MLC2 phosphorylation in a manner dependent on stretch magnitude and cell
type.
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RhoA, myosin regulatory light chain, perijunctional actomyosin ring, epithelial, lung injury, mechanical
ventilation
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Rho kinase signaling pathways during stretch in primary alveolar epithelia
Brian C. DiPaolo and Susan S. Margulies

Abstract
Alveolar epithelial cells (AECs) maintain integrity of the bloodgas barrier with actinanchored intercellular tight junctions. Stretched
type Ilike AECs undergo magnitude and frequencydependent actin cytoskeletal remodeling into perijunctional actin rings. On the basis
of published studies in human pulmonary artery endothelial cells (HPAECs), we hypothesize that RhoA activity, Rho kinase (ROCK)
activity, and phosphorylation of myosin light chain II (MLC2) increase in stretched type Ilike AECs in a manner that is dependent on
stretch magnitude, and that RhoA, ROCK, or MLC2 activity inhibition will attenuate stretchinduced actin remodeling and preserve
barrier properties. Primary type Ilike AEC monolayers were stretched biaxially to create a change in surface area (ΔSA) of 12%, 25%,
or 37% in a cyclic manner at 0.25 Hz for up to 60 min or left unstretched. Type Ilike AECs were also treated with Rho pathway
inhibitors (ML7, Y27632, or blebbistatin) and stained for Factin or treated with the myosin phosphatase inhibitor calyculinA and
quantified for monolayer permeability. Counter to our hypothesis, ROCK activity and MLC2 phosphorylation decreased in type Ilike
AECs stretched to 25% and 37% ΔSA and did not change in monolayers stretched to 12% ΔSA. Furthermore, RhoA activity decreased in
type Ilike AECs stretched to 37% ΔSA. In contrast, MLC2 phosphorylation in HPAECs increased when HPAECs were stretched to 12%
ΔSA but then decreased when they were stretched to 37% ΔSA, similar to type Ilike AECs. Perijunctional actin rings were observed in
unstretched type Ilike AECs treated with the Rho pathway inhibitor blebbistatin. Myosin phosphatase inhibition increased MLC2
phosphorylation in stretched type Ilike AECs but had no effect on monolayer permeability. In summary, stretch alters RhoA activity,
ROCK activity, and MLC2 phosphorylation in a manner dependent on stretch magnitude and cell type.
Keywords: RhoA, myosin regulatory light chain, perijunctional actomyosin ring, epithelial, lung injury, mechanical ventilation
MECHANICAL VENTILATION

is a critical intervention for particular lifethreatening conditions but has been implicated in pulmonary injury

because of the delivery of large gas volumes to localized lung regions, highmagnitude basement membrane (86) and pulmonary alveolar
epithelial cell (AEC) biaxial stretch, and increased bloodgas barrier permeability (33, 48). Cultured rat AEC monolayers with type I
features used to mimic the alveolar epithelium in vitro (12, 19, 27, 55, 67) have been shown to exhibit perijunctional Factin rings
(PJARs) and to increase monolayer permeability in response to highmagnitude biaxial stretch levels, which are analogous to pathological
ventilator volumes (17, 29). However, little is known about the underlying mechanistic pathways involved in PJAR rearrangement and the
influence of PJAR rearrangement on monolayer permeability in type I AECs.
The actin cytoskeleton is a mechanosensitive loadbearing structure in the cell that assists in cellcell adhesion (3, 14, 15, 21, 29), and
anchors tight junction (TJ) proteins (34, 58). The PJAR, which some refer to as the perijunctional actomyosin ring (87), is a specific
morphological conformation of Factin formed rapidly in biaxially stretched rat type Ilike AECs (29) and endothelial cells (91), and has
been shown to contain the contractile protein myosin in endothelial cells (7, 93). However, it is not yet understood if myosin contracts to
rearrange into PJARs in response to stretch and if this contraction would provide enough force to increase the TJmediated paracellular
permeability found previously (16, 17). Mechanistic pathways responsible for stretchinduced actin rearrangement into PJARs are also
poorly understood in type Ilike AECs.
Myosin II has been shown to crosslink with filamentous actin directly, and numerous actinbinding proteins (36, 46) contribute to PJAR
structure (93) and change its conformation (32) and activity based on mechanical stretch pathways in other cell types (8, 75, 90). It is not
yet understood how significantly myosin II interacts in PJAR contraction and TJmediated paracellular permeability during stretch. PJAR
contraction has been shown to have a causal relationship with Rhomediated phosphorylation of myosin light chain II (MLC2) in various
cell types (11, 79). Nonmuscle myosin II is activated through the Rho pathway and provides contractile force via phosphorylation of
MLC2 at Thr 18 and Ser 19 (38, 40, 60, 74), with force generation greater with phosphorylation at both residues than with
monophosphorylation (61). MLC2 can be inhibited with phosphorylation at Ser 1 and Ser 2 (38, 41, 60, 74), resulting in reduced myosin
affinity for actin filaments.
MLC2 can be pharmacologically inhibited with blebbistatin (96), an inhibitor of myosin II ATPase. Active (GTPbound) Rho activates
Rho kinase (ROCK) (43). ROCK phosphorylates the myosin binding subunit of myosin phosphatase (MP), inhibiting its activity and, thus,
increasing phosphorylation of MLC2 of myosin II (22, 49, 72, 83) and its contractile force (61). Additionally, ROCK directly
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phosphorylates MLC2 at Thr 18 and Ser 19 (2), with a higher affinity for Ser 19 (40, 83), promoting actin filament assembly (20, 26). ROCK
can be inhibited by Y27632 (35, 69, 94) and has been shown to result in decreased MLC2 phosphorylation (5). MP can be inhibited by
calyculinA (23, 42) and has been shown to increase MLC2 phosphorylation (5). Myosin light chain kinase (MLCK) has also been found
to phosphorylate MLC2 (45) at Thr 18 and Ser 19 (2). MLCK is activated by ERK (50) and can be inhibited by ML7, a membrane
permeable agent (52). ROCKmediated MLC2 phosphorylation has been shown to be confined to cell central areas, while MLCK
mediated MLC2 phosphorylation has been shown to localize at cell peripheral locations in fibroblasts (83). Finally, numerous other
signaling proteins may contribute to Rho pathway regulation during stretch (56, 66, 80). We hypothesize that type Ilike AECs will
activate the Rho pathway during stretch. We also hypothesize an increase in RhoA and ROCK activity, phosphorylation of MLC2, and
rearrangement into PJARs. We further hypothesize that inhibition of these pathways will inhibit rearrangement into PJARs and attenuate
the stretchinduced increase in monolayer permeability.
Others have shown activation of the Rho pathway and have characterized its influence on the actin cytoskeleton (1, 8–10, 47, 51, 77), TJ
protein, and monolayer permeability properties in stretched endothelial cells and other cell types (8, 25, 65, 68, 75, 88, 90). Furthermore,
others have implicated the Rho pathway and its effect on actin structure, TJ protein distribution, and TJmediated paracellular
permeability in unstretched epithelial cells (13, 39, 59, 64, 76, 78, 88–90). However, there is a paucity of studies investigating these
pathways and relationships in stretched pulmonary alveolar cells. We investigated the MLCK, ROCK, and MLC2 pathways and their
effect on cytoskeletal rearrangement into PJARs in type Ilike AECs.
The goals of the present study are to test whether stretchinduced PJAR rearrangement is dependent on the ROCK and MLC2mediated
pathway. Our overall hypothesis is that rapid cytoskeletal remodeling and rearrangement into PJARs are activated by ROCK accompanied
downstream by MLC2 activation. We tested functional relationships by inhibiting this pathway and expected that it would inhibit PJAR
rearrangement.

MATERIALS AND METHODS
Primary rat type I-like AEC isolation. Alveolar type II cells were isolated from male SpragueDawley rats (190–300 g) based on a method
reported by Dobbs et al. (31) with slight modification (29, 86). The animal protocols were reviewed and approved by the University of
Pennsylvania Institutional Animal Care and Use Committee. Cells were seeded at 1.0 × 106 cells/cm2 onto fibronectincoated (10 μg/cm2;
Invitrogen) flexible Silastic membranes (Specialty Manufacturing, Saginaw, MI) in customdesigned wells (85). The cells were cultured
for 4 days at 37°C in 5% CO2 in MEM + FBS, which was replaced daily. After 4 days, the cells had adopted alveolar type I features (12,
19, 24, 27, 67, 70), including the expression of RTI40, and had grown to a confluent monolayer. Monolayers were then serumdeprived in
DMEM (Mediatech, Manassas, VA) supplemented with 20 mM HEPES (Sigma) for 3 h and stretched biaxially across a range of
physiologically relevant magnitudes, including 12%, 25%, or 37% change in surface area (ΔSA), roughly corresponding to 64%, 86%, and
100% total lung capacity, respectively (85).
Human pulmonary artery endothelial cell culture. Human pulmonary artery endothelial cells (HPAECs, passages 8–10; provided by Dr.
Christopher Chen, University of Pennsylvania) were seeded at 0.163 × 106 cells/cm2 onto collagen Icoated (5 μg/cm2 overnight; BD
Biosciences, San Jose, CA) flexible Silastic membranes in customdesigned wells (85), similar to a culture method described elsewhere
(8). The cells were cultured for 48 h at 37°C in 5% CO2 in epithelial basal medium (EBM2, Lonza, Basel, Switzerland) supplemented
with epithelial growth medium (hydrocortisone, hEGF, VEGF, hFGFB, R3IGFI, ascorbic acid, heparin, and gentamicinamphotericin
B; EGM2, Lonza), 10% FBS, 1% Lglutamine, and 1% 1:1 penicillinstreptomycin.
Western blot measurement of MLC2 phosphorylation. Cells were lysed and protein content was quantified by a method similar to that described
elsewhere (5, 8, 69). Serumdeprived monolayers were stretched biaxially to 12%, 25%, or 37% ΔSA cyclically at 0.25 Hz for 0
(unstretched), 1, 10, 30, or 60 min. A second group of monolayers were pretreated with the MP inhibitor calyculinA (Cell Signaling
Technology, Beverly, MA) at 10 nM for 60 min or with DMSO as vehicle control and then stretched biaxially to 25% ΔSA cyclically at
0.25 Hz for 0 (unstretched) or 10 min. A third group of HPAEC monolayers (with serum) were stretched to 12%, 25%, or 37% ΔSA
cyclically at 0.25 Hz for 0 (unstretched) or 30 min.
Monolayers (3 wells/lysate) were washed twice with icecold Dulbecco's PBS (DPBS), lysed, and resolved by SDSPAGE and
immunoblot, as described previously (8). Membranes were incubated overnight with one of the following primary antibodies: antiMLC2,
antiphosphorylated (Ser 19) MLC2, or antiphosphorylated (Thr 18/Ser 19) MLC2 (all from Cell Signaling Technology) or anti
phosphorylated (Ser 1) myosin light chain (ECM Biosciences, Versailles, KY). Membranes were then incubated with horseradish

peroxidase (HRP)conjugated secondary antibody (Santa Cruz Biotechnology, Santa Cruz, CA).
Immunoreactive proteins were detected with enhanced chemiluminescence (ECL Plus, GE Healthcare Biosciences, Piscataway, NJ).
The relative density of the protein in the bands was quantified by scanning densitometry in ImageJ (version 1.43j) based on optimization
described by Gassmann et al. (37). Background intensity for each lane was subtracted from blot intensity. Protein density was normalized
by the unstretcheduntreated density. Membranes were reprobed with the relevant total protein antibody or with antiGAPDH (Millipore,
Billerica, MA) to ensure equivalent protein loading (30).
Normalized density of the phosphorylated protein was divided by normalized density of the respective total protein or GAPDH signal and
reported. To test the effect of stretch, animal average normalized density values (≥3 animals/group) were compared with timematched
unstretched controls using a twoway ANOVA with post hoc Dunnett's test (95) in JMP (version 8.0, SAS Institute, Cary, NC). To test
the effect of treatment, animal average normalized density values (≥3 animals/group) were compared with timematched vehicle controls
as well as unstretcheduntreated controls using a twoway ANOVA with TukeyKramer post hoc analysis (95) in JMP.
RhoA activity assay. Endogenous RhoA activity was quantified using an in vitro colorimetric GLISA kit (catalog no. BK124, Cytoskeleton,
Denver, CO) according to the manufacturer's protocol. Serumdeprived monolayers were stretched biaxially to 37% ΔSA cyclically at
0.25 Hz for 0 (unstretched), 10, or 60 min, washed twice with icecold DPBS, and then lysed and loaded equivalently (20 μg) into a 96
well plate. Active (GTPbound) RhoA in each lysate was captured with immobilized rhotekin Rho binding domain, while inactive RhoA
was not bound and was washed away. The wells were then immunostained with RhoA antibody and HRPconjugated secondary antibody.
The optical density of the HRP reaction was quantified at 490 nm on a microplate reader (model ELx800, BioTek, Winooski, VT).
Background optical density was subtracted from each experimental optical density measurement.
The optical density of each experimental sample (2 replicates/sample, 2 samples/animal, ≥5 animals/group) was divided by the respective
optical density for the control (unstimulateduntreated) sample to calculate the normalized RhoA activity level. To test the effect of
stretch, animal average normalized RhoA activity values were compared with timematched unstretched controls using a oneway
ANOVA with post hoc Dunnett's test (95) in JMP.
ROCK activity assay. Endogenous ROCK activity was quantified using an in vitro kinase assay (Cell Biolabs, San Diego, CA) with
recombinant MP target subunit 1 as substrate, similar to the method described elsewhere (6, 54). Serumdeprived monolayers were
stretched biaxially to 12%, 25%, or 37% ΔSA cyclically at 0.25 Hz for 0 (unstretched), 10, or 60 min.
Monolayers (3 wells/lysate) were washed twice with icecold DPBS, scraped in radioimmunoprecipitation assay buffer with 5 mM
EDTA, 2 μg/ml pepstatin, 2 mM sodium fluoride, 2 mM sodium orthovanadate, and protease inhibitor cocktail (Complete Mini, Roche,
Indianapolis, IN), sonicated, and then loaded into the kinase assay equivalently.
After resolving by SDSPAGE and immunoblot, membranes were probed with antiphosphorylated (Thr 696) MP target subunit 1 to
determine sample recombinant MP target subunit 1 phosphorylation by ROCK (ROCK activity) and with GAPDH to normalize the signal
to sample total protein (30). Protein density was normalized by the unstretcheduntreated density. Normalized density of phosphorylated
MP target subunit 1 was divided by normalized density of the GAPDH signal and reported.
MLC2 immunofluorescence and F-actin staining. Monolayers were pretreated with the myosin II ATPase activity inhibitor blebbistatin, MLCK
inhibitor ML7, or ROCK inhibitor Y27632 (all 10 μM for 60 min; EMD Chemicals, Gibbstown, NJ) or with DMSO as vehicle control
and then stretched biaxially to 37% ΔSA cyclically at 0.25 Hz for 0 (unstretched) or 60 min and stained for Factin (phalloidin;
Invitrogen, Carlsbad, CA), Gactin (DNase I; Invitrogen), and doublestranded DNA (4′,6diamidino2phenylindole; Invitrogen). An
additional group of monolayers were stretched to 37% ΔSA at 0.25 Hz for 0 or 60 min and immunostained for MLC2 using antiMLC2 or
antiphosphorylated (Thr 18/Ser 19) MLC2 (Cell Signaling Technology). Monolayers were mounted on slides, and images were captured
with an epifluorescence microscope (Eclipse TE300, Nikon, Melville, NY) with a ×40 objective with constant intensity settings. Inhibitor
concentration and treatment time were chosen on the basis of previously published studies and an initial doseresponse experiment. Each
inhibitor was also tested at 5 and 50 μM, along with incubation times of 30 min and 2 h, with equivalent results shown here.
F- and G-actin content quantification. The F and Gactin content in rat type Ilike AEC monolayers was quantified using an in vivo assay
(catalog no. BK037, Cytoskeleton) according to the manufacturer's protocol. Briefly, monolayers were pretreated with the myosin II
ATPase activity inhibitor blebbistatin or ROCK inhibitor Y27632 (both 10 μM for 60 min) or with DMSO as vehicle control and then
stretched biaxially to 37% ΔSA cyclically at 0.25 Hz for 0 (unstretched) or 10 min. Monolayers were then lysed into Factin stabilization
buffer, homogenized, and centrifuged at 100,000 g for 60 min, all at 37°C, and then separated into supernatant (Gactin) and pellet (F

actin, resuspended in 10 μM cytochalasin D). The fractions were loaded equivalently (43.5 μg) into a gel, resolved for SDSPAGE and
immunoblot, and probed with antiGactin. Membranes were incubated with HRPconjugated secondary antibody, and the relative density
of the protein in the bands was quantified by scanning densitometry in ImageJ (version 1.43j) based on optimization described elsewhere
(37). Background intensity for each lane was subtracted from blot intensity. Protein density was normalized by the unstretchedvehicle
control density.
Monolayer permeability. Others have shown that largersized molecules were able to cross the epithelium of whole lungs that had been
inflated statically to high volumes (33, 48). More recently, the use of a customaltered deformable porous copolyester membrane
permitted the measurement of paracellular transport of differentsized tracers across stretched monolayers (16), although this membrane
is severely limited in availability. Because of the lack of a deformablepermeable monolayer substrate, there is a paucity of data
measuring intercellular tracer transport and transepithelial resistance (TER) between the apical and basal surface of a cyclically
stretched cultured monolayer. Thus paracellular permeability was assessed by monitoring the flux of the fluorescent tracer BODIPY
ouabain across the monolayer, a novel method that can be carried out on our standard flexible Silastic nonpermeable membranes, as
previously described (17). Using this method, Cavanaugh et al. (17) showed that the BODIPYouabain tracer was not internalized by
cells, did not undergo receptormediated endocytosis, did not bind due to plasma membrane rupture, and did not bind nonspecifically; thus
they hypothesized that it was transported across the epithelial monolayer via a paracellular, not a transcellular, route. Briefly, the apical
surface of the monolayer was bathed in DMEM + HEPES containing 2 μM BODIPYouabain (radius ∼20 Å; Invitrogen), a fluorescent
tracer that has a high affinity for the extracellular domain of the transmembrane Na+ K+ ATPase (44, 82) found on the basolateral
surface of type Ilike AECs (92), for 60 min during stretch (or for 60 min on unstretched monolayers). Monolayers were pretreated with
the MP inhibitor calyculinA (Cell Signaling Technology) at 10 nM for 10 min or with DMSO as vehicle control and then stretched
biaxially to 25% ΔSA cyclically at 0.25 Hz for 0 (unstretched), 10, or 60 min. After stretch, the apical surface was rinsed three times
with dyefree DMEM + HEPES and imaged (×10 objective) using constant exposure, aperture, and fluorescence intensity settings.
The maximum pixel intensity in the background of unstretcheduntreated monolayers was measured and used as a threshold to exclude
unstained regions. The percentage of each image area (3 images/well, 3 wells/animal, from ≥3 animals/group) above the threshold
intensity was determined and then divided by the respective value for the unstretchedvehicle control group to calculate the normalized
area percentage (nArea) of each image. To test the effect of stretch, animal average nArea values were compared with timematched
unstretchedcontrol values using a oneway ANOVA with post hoc Dunnett's test (95) in JMP. To test the effect of treatment, animal
average nArea values were compared with timematched vehicle controls, as well as unstretcheduntreated controls, using a twoway
ANOVA with TukeyKramer post hoc analysis (95) in JMP.

RESULTS
RhoA and ROCK activity is reduced with stretch and is dependent on stretch magnitude. We hypothesized that actin cytoskeletal remodeling during
rearrangement into PJARs would be preceded or accompanied by an increase in RhoA and ROCK activity. However, quantitative activity
assay data refuted our hypothesis: RhoA activity decreased at 10 and 60 min in monolayers stretched to 37% ΔSA at 0.25 Hz compared
with unstretched monolayers (Fig. 1). Furthermore, ROCK activity decreased at 60 min in monolayers stretched to 25% ΔSA at 0.25 Hz
and at 10 min in monolayers stretched to 37% ΔSA at 0.25 Hz but was not changed in monolayers stretched to 12% ΔSA at 0.25 Hz
compared with unstretched monolayers (Fig. 2). Thus RhoA and ROCK activity decreased with stretch, and ROCK activity was sensitive
to stretch magnitude and time.

Fig. 1.
RhoA activity is dependent on stretch. RhoA activity was reduced in monolayers stretched to 37% change in surface area
(ΔSA) at 0.25 Hz for 10 and 60 min compared with unstretched (UNS) monolayers. RhoA activity was quantified using an
in vitro ...

Fig. 2.
Rho kinase (ROCK) activity is dependent on stretch magnitude and time. ROCK activity was reduced in monolayers
stretched for 60 min to 25% ΔSA at 0.25 Hz and for 10 min to 37% ΔSA at 0.25 Hz but not in monolayers stretched to
12% ΔSA ...

MLC2 phosphorylation is reduced with stretch and is dependent on stretch magnitude. Myosin II has been shown to interact directly with Factin
stress fibers in other cell types (93). We hypothesized that MLC2 would colocalize with PJARs, which exhibit rapidly in stretched type I
like AEC monolayers (29). We found that dualphosphorylated (Thr 18/Ser 19) MLC2 (Fig. 3A) and total MLC2 (Fig. 3B) colocalize with
centrally located Factin stress fibers in unstretched monolayers (Fig. 3). With 60 min of stretch to 37% ΔSA at 0.25 Hz (Fig. 3), dual
phosphorylated MLC2 redistributed homogeneously throughout the cell, with minor perijunctional staining, comparable to the rapid
rearrangement of Factin into PJARs. Additionally, the overall intensity of dualphosphorylated MLC2 decreased with stretch. With
stretch, total MLC2 localized more centrally within the cell. These data support our hypothesis that MLC2 redistributes and becomes
dephosphorylated with stretch in type Ilike AEC monolayers.

Fig. 3.
Phosphorylated myosin light chain II (MLC2) in stretched and unstretched monolayers. Rat type Ilike AEC monolayers
before (unstretched) and after stretch to 37% ΔSA at 0.25 Hz for 60 min were stained for Factin with phalloidin (red),
nuclei ...

MLC2 can be activated when phosphorylated at Thr 18 and Ser 19 (40). MLC2 phosphorylation data correlate well with ROCK activity
data, showing a decrease in phosphorylation with stretch and stretch magnitude dependence. In monolayers stretched to 25% ΔSA at 0.25
Hz, MLC2 dual phosphorylation (Thr 18/Ser 19) was decreased at 1, 10, 30, and 60 min (Fig. 4) and monophosphorylation (Ser 19) was
decreased at 10 min (0.534 ± 0.117) compared with unstretched monolayers. Similarly, in monolayers stretched to 37% ΔSA at 0.25 Hz,
MLC2 dual phosphorylation was decreased at 1, 10, 30, and 60 min (Fig. 4) compared with unstretched monolayers. Dualphosphorylated
MLC2 was also lower in monolayers stretched to 25% and 37% ΔSA at 0.25 Hz than in monolayers stretched to 12% ΔSA at 0.25 Hz (
Fig. 4) at all times, which was not significantly different from dualphosphorylated MLC2 in unstretched monolayers. Thus MLC2
phosphorylation (Thr 18/Ser 19 and Ser 19) decreased with stretch and was sensitive to stretch magnitude.

Fig. 4.
MLC2 phosphorylation (Thr18 /Ser19 ) is dependent on stretch magnitude. Dual phosphorylation of MLC2 is reduced at
all times in monolayers stretched to 25% and 37% ΔSA at 0.25 Hz compared with unstretched dualmonolayers and
monolayers stretched ...

MLC2 activity can be inhibited by phosphorylation at Ser 1 (41, 74), additionally resulting in reduced myosin affinity for actin filaments.
Monolayers stretched for 10 min to 25% ΔSA at 0.25 Hz showed no change in phosphorylated (Ser 1) MLC2 compared with unstretched
monolayers (not shown). Thus stretch did not affect MLC2 phosphorylation at Ser 1 in type Ilike AEC monolayers.
MLC2 is phosphorylated with calyculin-A. Hypothesizing that stretchinduced PJAR formation and increased monolayer permeability required
decreased MLC2 activation, we used calyculinA to inhibit MP in stretched monolayers to recover MLC2 phosphorylation to unstretched
levels. As hypothesized, MLC2 phosphorylation (Thr 18/Ser 19) was higher in monolayers pretreated with 10 nM calyculinA for 60 min
and stretched to 25% ΔSA at 0.25 Hz for 10 min (Fig. 5A) than in vehicle control monolayers stretched to the same magnitude and for the
same duration (Fig. 5A) and monolayers left unstretched and untreated. Unstretched monolayers pretreated with calyculinA also show
increased MLC2 phosphorylation (Thr 18/Ser 19) compared with vehicle control monolayers. Similarly, Bhadriraju et al. (5) used calyculin
A in A10 rat aortic smooth muscle cells to increase MLC2 phosphorylation and contractility. Thus the decrease in MLC2 phosphorylation
in stretched type Ilike AECs is via MPdependent pathways.

Fig. 5.
MLC2 phosphorylation (Thr18 /Ser19 ) can be activated with calyculinA, but this did not affect paracellular permeability.
A: vehicle control (VC) monolayers stretched to 25% ΔSA at 0.25 Hz for 10 min show a reduction in phosphorylation
(Thr18 /Ser ...

Since we found that phosphorylation of MLC2 decreases with highmagnitude stretch, we hypothesized that inhibition of the MLC2
response with stretch using calyculinA would attenuate the stretchinduced increase in paracellular permeability. Previously, normalized
area stained by the fluorescent tracer BODIPYouabain (nArea) was significantly higher in monolayers stretched to 25% ΔSA at 0.25 Hz
for 10 and 60 min than in unstretcheduntreated controls (17). However, nArea in monolayers stretched at the same magnitude for the
same durations and pretreated with 10 nM calyculinA for 10 min was higher at 60 min than in unstretcheduntreated monolayers, and was
not different from timematched stretchedvehicle controls (Fig. 5B). While others have shown that calyculinA increases epithelial and
endothelial permeability (57, 63, 78), recovering phosphorylation of MLC2 in stretched type Ilike AEC monolayers above unstretched
levels does not attenuate the stretchinduced increase in paracellular permeability.
PJARs are found in unstretched monolayers with blebbistatin. We initially hypothesized that rapid actin cytoskeletal rearrangement to PJARs
would be preceded or accompanied by an increase in ROCK and MLC2 activity in stretched type Ilike AEC monolayers. However, our
data showed that ROCK activity and MLC2 phosphorylation decreased with stretch. Similarly, inhibition of myosin II ATPase
(blebbistatin), ROCK (Y27632), or MLCK (ML7) did not prevent rearrangement into PJARs in stretched monolayers (Fig. 6).
Interestingly, however, in unstretched monolayers, inhibition of myosin II ATPase (blebbistatin), but not MLCK (ML7), results in a
PJARlike structure, similar to PJAR rearrangement in stretcheduntreated monolayers (Fig. 6). Additionally, in unstretched monolayers,
inhibition of ROCK (Y27632) and myosin II ATPase (blebbistatin) results in a lack of centrally located Factin stress fibers. Thus
stretchinduced PJAR rearrangement was not suppressed with inhibition of myosin II ATPase, ROCK, or MLCK. Furthermore, a PJAR
like structure was found in unstretched monolayers with inhibition of myosin II ATPase.

Fig. 6.
Effect of biaxial stretch and pathway inhibitors on F and Gactin. Rat type Ilike alveolar epithelial cell (AEC)
monolayers labeled with phalloidin for Factin (red), DNase I for Gactin (green), and DAPI for doublestranded DNA
(blue) were left unstretched ...

Additionally, we found no significant difference in F and Gactin content [fold change relative to unstretched vehicle control (means ±
SE)] of monolayers stretched to 37% ΔSA at 0.25 Hz for 10 min (0.79 ± 0.31 and 1.31 ± 0.19 for F and Gactin, respectively) compared
with unstretched monolayers (1.00 ± 0.34 and 1.00 ± 0.19 for F and Gactin, respectively) or in unstretched monolayers treated with
blebbistatin (0.88 ± 0.38 and 1.57 ± 0.23 for F and Gactin, respectively) or Y27632 (0.75 ± 0.44 and 0.97 ± 0.26 for F and Gactin,
respectively) compared with vehicle control. Thus we cannot reject the possibility that PJARlike structures in type Ilike AEC
monolayers could be Factin preserved from depolymerization or rearranged Factin or both.
MLC2 phosphorylation depends on cell type. Behavior of primary rat type Ilike AEC monolayers was compared with behavior of HPAEC
monolayers. As previously reported (8), MLC2 phosphorylation (Thr 18/Ser 19) increased in HPAEC monolayers stretched biaxially to 12%
ΔSA at 0.25 Hz for 30 min. However, MLC2 phosphorylation decreased in monolayers stretched to 37% ΔSA at 0.25 Hz for 30 min and
did not change in monolayers stretched to 25% ΔSA at 0.25 Hz for 30 min compared with unstretched HPAEC monolayers (Fig. 7).
Phosphorylation was greater in monolayers stretched to 12% ΔSA than in monolayers stretched to 25% and 37% ΔSA. Thus, MLC2
phosphorylation at lowmagnitude stretch agrees with previous findings, but like type Ilike AECs, phosphorylated MLC2 decreased
dramatically at highermagnitude stretch.

Fig. 7.
MLC2 phosphorylation (Thr18 /Ser19 ) in human pulmonary artery endothelial cells (HPAECs) is stretch magnitude
dependent. Dual phosphorylation of MLC2 increased in monolayers stretched biaxially to 12% ΔSA at 0.25 Hz for 30
min and decreased in ...

DISCUSSION
We found that RhoA activity, ROCK activity, and MLC2 phosphorylation decreased with highmagnitude stretch of primary type Ilike
AEC monolayers. Unlike primary type Ilike AECs, HPAEC monolayers stretched for 30 min to 12% ΔSA at 0.25 Hz showed increased
MLC2 phosphorylation, similar to results published previously by Birukov et al. (8) in HPAECs stretched for 30 min of 18% cyclic
elongation without exposure to thrombin. Furthermore, we demonstrated that MLC2 phosphorylation in HPAECs is stretch magnitude
dependent, similar to our findings in type Ilike AEC monolayers, with decreased MLC2 phosphorylation at highmagnitude (37% ΔSA)
stretch. We speculate that high biaxial stretch magnitudes (25% and 37% ΔSA) used in type Ilike AEC monolayer models, while
physiologically relevant (85), are significantly higher than strain magnitudes typically experienced by endothelial cells utilized in
numerous studies that show RhoA, ROCK, and MLC2 activation with stretch. Thus type Ilike AEC monolayers respond differently by
reducing activation of ROCK and MLC2. We conclude that MLC2 phosphorylation in stretched HPAEC monolayers is significantly
different from that in primary AECs at lowmagnitude stretch, although the response is similar at high magnitudes. We have shown that
rescuing MLC2 phosphorylation during stretch has no effect on monolayer permeability. Finally, unstretched monolayers in which MLC2
activity is inhibited show rearrangement into PJARs.
RhoA and ROCK activity is reduced with stretch and is dependent on stretch magnitude. Previous studies have investigated the ROCKMLC2
pathway during stretch in other cell types (1, 4, 28, 71). Endothelial cells exposed to elongation show a rapid (<10 min) increase in MLC2
phosphorylation via ROCK and MLCK (8, 10, 51), remodeling of actin to form PJARs (8, 47), and Rho activation and peripheral
localization (77). RhoA activity was increased in alveolar type II cells isolated from rats exposed to hightidalvolume mechanical
ventilation (28). In unstretched cells, phosphorylation of MLC2 was found to alter actin arrangement rapidly by constriction of PJARs, to
increase detergentsoluble (independent of actin) TJ protein content (65, 88, 90), to increase TJ permeability (68), and to redistribute
zonula occludens1 (ZO1) and occludin (75). Numerous studies have established the link between stretch and ROCK activation, MLC2
activation, rearrangement into PJARs, and monolayer permeability in endothelial cells (1, 8–10, 47, 77).
In unstretched cells, the ROCKMLC2 pathway has also been shown to have a major influence on TJ protein coupling and monolayer
permeability. For example, in the T84 cell line, constitutively active RhoA redistributed occludin, ZO1, claudin1, claudin2, and
junctional adhesion molecule1, increased detergent solubility of claudin1 and claudin2, and intensified PJARs. In contrast, dominant
negative RhoA abolished PJARs (13) in T84 cells, while ROCK inhibition with Y27632 decreased PJAR intensity, decreased TER, and
colocalized a subpool of ROCK and ZO1 (90). Furthermore, MP inhibition with calyculinA prevented infectioninduced occludin
relocalization and decrease in resistance in T84 cells (78). LatrunculinA depolymerized actin in MadinDarby canine kidney cells,
resulting in reduction of TER within 5 min, internalization of occludin, and abolishment of PJARs (76). In Caco2 cells, inactivation of
the Na+ glucose cotransporter SGLT1 resulted in increased TER, which was reversible by MLCK inhibition. SGLT1 activation increased
MLC2 phosphorylation and was reversible by MLCK inhibition via ML9 (89).
In summary, these studies in unstretched cells show parallel changes and associations between PJAR morphology, TJ protein distribution,
and permeability modulated by Rho, MLCK, ROCK, and MLC2. Previously, we reported stretch magnitude and frequencydependent
PJAR formation (29) and a stretchinduced increase in paracellular permeability (17, 18) in type Ilike AEC monolayers. We
hypothesized that RhoA and ROCK were activated with stretch and that the stretchinduced increase in monolayer permeability could be
attenuated with pharmacological inhibition of ROCK. Counter to our hypothesis, we found that RhoA activity and downstream ROCK
activity are significantly decreased with highmagnitude stretch of type Ilike AEC monolayers, revealing that other pathways may be
responsible for rearrangement into PJARs at highmagnitude stretch. Additionally, while we found a decrease in RhoA activity at 10 and
60 min of stretch to 37% ΔSA at 0.25 Hz, ROCK activity was decreased at only 10 min. We speculate that other pathway intermediates,
including Ras and ERK (73), may be involved in the signaling between RhoA and ROCK in stretched type Ilike AEC monolayers.
MLC2 phosphorylation is reduced with stretch and is dependent on stretch magnitude. MLC2 phosphorylation data correlated well with ROCK
activity data, showing a stretch magnitudedependent decrease in MLC2 phosphorylation (Thr 18/Ser 19) with highmagnitude stretch (25%

and 37% ΔSA) but no change at lowmagnitude stretch (12% ΔSA). While MLC2 phosphorylation was decreased at all times in
monolayers stretched to 25% and 37% ΔSA at 0.25 Hz, ROCK activity was decreased only at 60 min of stretch to 25% ΔSA and 10 min
of stretch to 37% ΔSA, evidence that additional pathways, including MLCK (45) and MP (49, 72), may contribute to the phosphorylation
state of MLC2 in stretched type Ilike AEC monolayers. MLC2 monophosphorylation at Ser 19, a site shown to have higher affinity for
ROCKmediated phosphorylation (40, 83), similarly decreased phosphorylation in stretched monolayers. Similarly, Mizutani et al. (62)
demonstrated a decrease in MLC2 phosphorylation (Thr 18/Ser 19) in NIH3T3 cells stretched for 1–2 h uniaxially at 10%. Thus MLC2
phosphorylation in type Ilike AEC monolayers subjected to highmagnitude stretch decreased; we speculate that this results in reduced
MLC2 activity and contractile force. Additionally, a minor amount of dualphosphorylated MLC2 was found to colocalize with Factin in
stretched monolayers. Others have shown MLC2 colocalization with Factin in other cell types (7, 93), and we speculate that MLC2
anchoring to the actin cytoskeleton is necessary for force generation. Together with previous data showing a rapid increase in actin
rearrangement during stretch (29) and minor MLC2 colocalization with stretchinduced PJARs, we speculate that monolayer tension may
diminish in stretched type Ilike AEC monolayers, previously demonstrated in other stretched cell types (15, 53, 84).
PJAR is found in unstretched monolayers with blebbistatin. Stretchinduced rearrangement into PJARs was unaffected by MLCK inhibition by
ML7, ROCK inhibition by Y27632, and MLC2 activity inhibition by blebbistatin under highmagnitude stretch conditions. Interestingly, a
PJARlike structure was found in unstretched monolayers treated with the MLC2 activity inhibitor, but not with the MLCK inhibitor. It is
not known if these PJARlike structures formed because of the presence of the inhibitor or if peripherally located Factin was preserved
from inhibitorinduced depolymerization. Additionally, unstretched monolayers treated with Y27632 or blebbistatin lack centrally located
Factin stress fibers found in unstretched vehicle control monolayers. Bhadriraju et al. (6) demonstrated reduced ROCK activity and
MLC2 phosphorylation that could not be rescued by constitutively active RhoA in endothelial cells with diminished actinmediated
extracellular matrix adhesion. Additionally, treatment with blebbistatin to reduce cellular tension resulted in decreased focal adhesions, as
well as reduced ROCK and MLC2 activity (6). Others have shown that injection of RhoA induces assembly of stress fibers and focal
contacts (4, 71). Furthermore, endothelial cells treated with sphingosine 1phosphate exhibit a thick cortical actin ring and enhanced
barrier and adhesion properties (81). Taken together with our data showing decreased ROCK and MLC2 activity with stretch and
reorganization into PJARs in unstretched monolayers with inhibition of myosin II ATPase, these previous studies lead us to speculate that
type Ilike AEC monolayer adhesion to the extracellular matrix may be reduced with highmagnitude biaxial stretch.
Summary. We have demonstrated that RhoA activity, ROCK activity, and MLC2 phosphorylation decrease with highmagnitude stretch of
primary type Ilike AEC and HPAEC monolayers. This inactivation is stretchmagnitudedependent and occurs via the MP pathway in
type Ilike AECs. We have shown that rescuing MLC2 phosphorylation during stretch has no effect on monolayer permeability. We have
demonstrated that, in unstretched type Ilike AEC monolayers, the actin cytoskeleton remodels to PJARs in the presence of the myosin II
ATPase inhibitor blebbistatin. Future studies should investigate pathways involved in actin remodeling and their effect on paracellular
permeability during stretch in order to explore opportunities to prevent ventilatorinduced lung injury.
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